Company Overview and News

2
ZNH / China Southern Airlines Co. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-06-19 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549
ZNH

1
ZNH / China Southern Airlines Co. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-06-19 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549
ZNH

1
ZNH / China Southern Airlines Co. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-06-19 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549
ZNH

20
4 Tariff-Proof Chinese Stocks to Consider | InvestorPlace

2018-06-18 investorplace
I’m not an expert in geopolitical analysis, nor am I remotely qualified to predict what President Donald Trump might do next. That said, it doesn’t take a doctorate degree in international relations to understand that the recent volatility in Chinese stocks is due to the White House hitting the reset button on North Korea.
ZNH 0941 0762 CHLKF CHL CHUFF SNP CHU 1055

1
ZNH / China Southern Airlines Co. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-06-15 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549
ZNH

2
Xiamen Airlines ‘epitome of China’s aviation industry’, says Chinese President Xi Jinping

2018-06-14 scmp
Xiamen Air lives up to president’s praise with over 200 Boeing jets, nearly 400 domestic and international routes and a strong financial performance
ZNH 1055

13
$12.9 Billion Airport Puts China's Biggest Airlines in a Battle for Dominance - Bloomberg

2018-06-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ZNH AICAF C6L AAL CHEAF AIRYY DLAKF SINGY UAL CEA 0694 0670 1055 0753 AIRC DLAKY DAL SINGF

1
ZNH / China Southern Airlines Co. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-06-08 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549
ZNH

8
SkyWest's (SKYW) May Block Hours Decline, Load Factor Up

2018-06-08 zacks
SkyWest Inc. (SKYW - Free Report) reported a 6.7% (10,500) year-over-year decline in block hours (a measure of aircraft utilization) to 145,300 in May 2018.
GATX ZNH EXPD UNP SKYW GMTA GMT 1055

8
Sacre bleu! Paris return from under a grand in House of Travel sale

2018-06-08 nzherald.co.nz
Return flights to Paris are on sale this weekend for $999 and Hawaii economy flights have dropped to below $600.
ZNH ANZLY AIR ANZFF ANZFY AIZ 1055

1
ZNH / China Southern Airlines Co. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-06-06 sec.gov
Form 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549
ZNH

16
There Aren’t Many Female Executives. The Airline Industry Has Even Fewer - Bloomberg

2018-06-04 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ZNH QABSD C6L AAL SINGY 0293 1055 CPCAY QABSY QUBSF QAN FLYB CPCAF DAL SINGF

15
10 Best Airline Stocks to Buy Right Now | InvestorPlace

2018-06-01 investorplace
But there are a couple other important trends to keep in mind that make this a good time to get in.
AVH ZNH SKYW CHEAF RYAOF CEA 0670 GOL RYAAY ALGT DAL AZUL

2
China Southern To Use Boeing 737 MAX On St. Petersburg Route

2018-05-30 aviationweek
BEIJING—China Southern Airlines will use Boeing 737-8s to operate a revived service between Urumqi in northwestern China and St Petersburg, Russia, replacing 757s. The carrier earlier said it would use 787-8s on the 4,730-km (2,580-mi.) route. Operated with 737s, the scheduled duration of the service is 6 hr. 10 min. China Southern retired its last 757 in March. The airline began flying between Urumqi and St.
ZNH 1055

1
ZNH / China Southern Airlines Co. Ltd. null

2018-05-28 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @(" @#0HR M,B P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X-"],(#8X+TQE;F=T M:" V,2]3(#,X/CYS=')E86T-"FC>[email protected][email protected]
ZNH

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

7h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

8h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: 169409109